About Alfa Cytology

Alfa Cytology stands at the forefront of biotechnology, specializing in the development and preclinical research of cancer therapies. Our distinguished team comprises senior biomedical scientists, bioinformatics experts, and oncologists, uniting to spearhead innovation in cancer treatment.

Drawing upon profound expertise and hands-on experience in cancer therapy, our dedicated team remains steadfast in pursuing groundbreaking therapies.

• Target identification
• Drug screening
• Formulation optimization
• Efficacy evaluation

Our work spans the entire spectrum of cancer therapy development.

In the preclinical research realm, we offer a comprehensive suite of services to support every phase of drug development.

• Cancer modeling
• Pharmacokinetics testing
• Toxicology testing

Striving not only for scientific excellence but also unwavering adherence to quality, safety, and ethical standards, we ensure rigorous compliance with regulatory guidelines at every research juncture.

Alfa Cytology aims to propel oncology forward through innovative therapy modalities and advanced research methodologies, ultimately offering enhanced therapeutic choices. Committed to leading the industry and fostering collaborative partnerships in advancing cancer care, we invite you to explore our services or reach out with any inquiries you may have. Get in touch with us today for further details.

Diagnostic Development Platform

Cancer Biomarker Discovery
Imaging Services
Multi-omics Services

Cancer Modeling Platform

Advanced Cellular Models
3D Tumor Modeling
PDX Model
CDX Model
Syngeneic Tumor Model

Therapeutic Development Platform

Small Molecule Drug
Cell Therapy
Gene Therapy

Antibody
Therapeutic Peptide
Cancer Vaccine